LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Matternet M2 first delivery drone to receive FAA design safety approval

...

Investor in Action: 5 Questions for Andrew Dudum of Hims & Hers

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

An inside look at a national, bilingual telemedicine service

Augmedix Reports Second Quarter 2022 Financial Results

Augmedix Announces Expanded Partnership with Adventist Health

The Top 100 Healthcare Technology Companies of 2022

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • Matternet M2 first delivery drone to receive FAA design safety approval

  • Investor in Action: 5 Questions for Andrew Dudum of Hims & Hers

  • Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

  • An inside look at a national, bilingual telemedicine service

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn